Digestive Disease Week 2019: SHG Technology in POISE Substudy to Quantify Liver Fibrosis
[STORY BY HEALIO]
Post-hoc analysis of data from a POISE substudy has shown reduction in fibrosis "supporting the overall trend of improvement or no progression in the histologic components of PBC," a rare autoimmune liver disease of intrahepatic bile ducts leading to progressive fibrosis and eventual cirrhosis, according to a researcher here.
"Measuring collagen content is emerging as a reliable method of quantifying liver fibrosis and has shown evidence of being an effective tool in [patients with] PBC," said Paul Pockros, MD, speaking at Digestive Disease Week.